20/20 Biolabs, Inc. (AIDX)
0.4651
-0.01
(-1.36%)
USD |
NASDAQ |
Sep 18, 16:00
0.48
+0.01
(+3.20%)
After-Hours: 20:00
20/20 Biolabs Enterprise Value : 3.263M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.263M |
| September 17, 2026 | 3.341M |
| September 16, 2026 | 3.455M |
| September 15, 2026 | 3.394M |
| September 14, 2026 | 3.942M |
| September 11, 2026 | 4.426M |
| September 10, 2026 | 4.185M |
| September 09, 2026 | 4.482M |
| September 08, 2026 | 4.645M |
| September 04, 2026 | 4.812M |
| September 03, 2026 | 5.056M |
| September 02, 2026 | 5.288M |
| September 01, 2026 | 5.106M |
| August 31, 2026 | 5.114M |
| August 28, 2026 | 5.210M |
| August 27, 2026 | 5.157M |
| August 26, 2026 | 4.462M |
| August 25, 2026 | 4.036M |
| August 24, 2026 | 3.914M |
| August 21, 2026 | 4.356M |
| August 20, 2026 | 3.863M |
| August 19, 2026 | 3.796M |
| August 18, 2026 | 3.888M |
| August 17, 2026 | 4.307M |
| August 14, 2026 | 4.291M |
| Date | Value |
|---|---|
| August 13, 2026 | 3.918M |
| August 12, 2026 | 3.213M |
| August 11, 2026 | 2.895M |
| August 10, 2026 | 3.167M |
| August 07, 2026 | 3.141M |
| August 06, 2026 | 3.101M |
| August 05, 2026 | 2.971M |
| August 04, 2026 | 3.151M |
| August 03, 2026 | 2.782M |
| July 31, 2026 | 2.773M |
| July 30, 2026 | 2.479M |
| July 29, 2026 | 2.935M |
| July 28, 2026 | 3.139M |
| July 27, 2026 | 3.080M |
| July 24, 2026 | 3.580M |
| July 23, 2026 | 3.838M |
| July 22, 2026 | 4.292M |
| July 21, 2026 | 4.276M |
| July 20, 2026 | 3.838M |
| July 17, 2026 | 3.906M |
| July 16, 2026 | 4.056M |
| July 15, 2026 | 4.326M |
| July 14, 2026 | 4.291M |
| July 13, 2026 | 4.546M |
| July 10, 2026 | 4.782M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 355.51M |
| Intelligent Bio Solutions, Inc. | 3.273M |
| Anteris Technologies Global Corp. | 541.09M |
| Quest Diagnostics, Inc. | 33.25B |
| Labcorp Holdings, Inc. | 32.59B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.506M |
| Revenue (Quarterly) | 0.7306M |
| Total Expenses (Quarterly) | 2.237M |
| EPS Diluted (Quarterly) | -0.2247 |
| Gross Profit Margin (Quarterly) | 41.71% |
| Profit Margin (Quarterly) | -206.2% |
| Earnings Yield | -155.5% |